HB150 Alabama 2013 Session

Updated Feb 27, 2026

Notable

Summary

Primary Sponsor: Jim McClendon
Republican
Session: Regular Session 2013
Title: Controlled Substances Prescription Database, membership of advisory committee, meetings further provided for, transmittal of information on controlled substances prescriptions, confidentiality of records, funding of database, Secs. 20-2-212, 20-2-213, 20-2-214, 20-2-215, 20-2-219 am'd.
Summary: HB150 creates and funds Alabama's Controlled Substances Prescription Database, expands the advisory committee, expands data access and confidentiality rules, and sets reporting and operational timelines.
What This Bill Does
The bill authorizes the department to establish and run a controlled substances prescription database and creates a new Alabama State Controlled Substance Database Trust Fund to finance it. It forms a Controlled Substances Prescription Database Advisory Committee with representatives from multiple professional organizations to advise on operations and security. It sets who can access the data (and for what purposes), requires reporting of prescribed substances by specific licensees, and outlines data elements to be transmitted. It also establishes confidentiality protections, potential disciplinary actions for noncompliance, and a timeline to become operational within 12 months after funds are certified.

Who It Affects
Licensed healthcare professionals (e.g., physicians, dentists, podiatrists, optometrists, veterinarians, pharmacists and their staff) and pharmacies: they must report controlled substance data, may have limited access to database information, may designate proxies to access on their behalf, and could face disciplinary action for failing to comply with reporting requirements.
State agencies, boards, law enforcement, Medicaid, and advisory bodies: they oversee and participate in the database, regulate access, manage the new funding trust, and coordinate ongoing operations and regulatory actions; they also ensure confidentiality and inter-state data sharing where permitted.

Key Provisions
Creation and funding of the Alabama State Controlled Substance Database and a separate revolving trust fund to finance development, implementation, and operation, with funds restricted to appropriation and budgeting processes.
Establishment of the Controlled Substances Prescription Database Advisory Committee with specified organizational representation; provisions for proxies, diversity requirements, and remote participation.
Permission for the department to contract with the State Board of Pharmacy to handle operational functions such as data collection, input, and transmission of controlled substance data.
Defined reporting requirements for pharmacies, mail order pharmacies, physicians/dentists/podiatrists/optometrists/veterinarians who dispense, and other designated entities, including required data elements (e.g., prescriber, date filled, patient information, NDC, quantity, dispensing source, and payment method).
Access rules detailing who may access the database (e.g., certifying boards, licensed practitioners under supervision, physicians, PAs, pharmacists, law enforcement with probable cause, Medicaid, department staff, and certain out-of-state programs) and the purposes for which access is allowed.
Confidentiality and privilege of database records are established; records are not public records and may be used only for investigations of law/regulatory actions, with existing business records excepted from immunity; reporting to licensing boards is mandatory when noncompliance occurs.
Operational timeline stating the database must become operational within 12 months after funding certification by the State Health Officer, with funds potentially sourced from grants, contributions, or other appropriations and remaining available for future years.

AI-generated summary using openai/gpt-5-nano on Feb 24, 2026. May contain errors — refer to the official bill text for accuracy.
Subjects: Controlled Substances